David R. Liu | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 劉如謙 | |||||||||
 Liu in 2012 | |||||||||
| Born | June 12, 1973 Riverside, California, U.S. | ||||||||
| Alma mater | Harvard University (BA) University of California, Berkeley (PhD) | ||||||||
| Organization | The Liu Group | ||||||||
| Known for | Nucleic acid templated chemistry directed evolution base editing prime editing | ||||||||
| Scientific career | |||||||||
| Fields | Organic chemistry | ||||||||
| Institutions | Harvard University | ||||||||
| Doctoral advisor | Peter G. Schultz | ||||||||
| Other academic advisors | E.J. Corey | ||||||||
| Chinese name | |||||||||
| Traditional Chinese | 劉如謙 | ||||||||
| |||||||||
David Ruchien Liu (Chinese: 劉如謙; born 1973) is an American molecular biologist and chemist. He is Richard Merkin Professor, Director of the Merkin Institute of Transformative Technologies in Healthcare, and Vice-Chair of the Faculty at the Broad Institute of Harvard University and the Massachusetts Institute of Technology.
Liu is also the Thomas Dudley Cabot Professor of the Natural Sciences and Professor of Chemistry and Chemical Biology at Harvard University and a principal investigator of the Howard Hughes Medical Institute.[1]
- ^ "David R. Liu". Liu Group. 2018-10-22. Retrieved 2019-04-02.